NEWBRYNewbury Pharmaceuticals ABNEWBRY info
$0.29info0.00%24h
Global rank34246
Market cap$5.66M
Change 7d-4.52%
YTD Performance-5.73%
SP500 benchmarkUnderperform
P/E-0.29
P/S5.63
Revenue$1.01M
Earnings-$1.90M
Dividend yield-
Main Sector
Healthcare

Newbury Pharmaceuticals AB (NEWBRY) Total Liabilities

NEWBRY Total Liabilities in 2022: $2.31M

According to Newbury Pharmaceuticals AB latest financial reports the total liabilities of NEWBRY is $2.31M, an increase of 29.79% to 2022. At the end of 2022 company had $1.78M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Newbury Pharmaceuticals AB is responsible for during its operational activities.

Newbury Pharmaceuticals AB (NEWBRY) Total Liabilities History from 2023 to 2022

-
Value:-

NEWBRY Total Liabilities by year

YearTotal liabilitiesChange
2023$2.31M29.79%
2022$1.78M317.95%
2021$425.04K-

View the Top Total Liabilies Stocks

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org